Endometriosis: Research
The question
To ask the Secretary of State for Health and Social Care, how much funding the Government has provided for endometriosis research in each of the last five years; and what proportion of Government-funded medicinal research that accounts for.
Answered by Andrew Gwynne
The Department funds research through the National Institute for Health and Care Research (NIHR). The following table shows how much funding the NIHR has awarded for endometriosis research, as well as that spend as a percentage of total urogynaecology research spend, for each year from 2019/20 to 2023/24:
Financial year | Spend | Proportion of total urogynaecology spend |
2019/20 | £493,945 | 8.9% |
2020/21 | £554,151 | 10.5% |
2021/22 | £973,089 | 16.8% |
2022/23 | £1,360,614 | 24.9% |
2023/24 | £1,325,329 | 21.9% |
This information reflects in-year payments to 10 research awards that were active during this time period. It does not reflect the total award value. The total award value for these awards, across their full duration, is £7,714,953.
In addition, between 2019/20 and 2023/24, there were 18 awards with relevance to endometriosis active on UK Research and Innovation’s (UKRI) portfolio. These awards had a total value of £8.43 million. The following table shows the in-year expenditure for this research, for each year from 2019/20 to 2023/24:
Financial year | In year spend | Percentage of spend versus UKRI research base outturn |
2019/20 | £585,662 | <1% |
2020/21 | £683,812 | <1% |
2021/22 | £1,017,417 | <1% |
2022/23 | £1,264,127 | <1% |
2023/24 | £1,589,230 | <1% |
The remaining spend is slated for future financial years.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →